Search

everythinglearnresearchcommunity

for

Search:↓

Anlotinib combined with taxane/capecitabine is more effective than bevacizumab for treating HER-2 negative metastatic breast cancer.

KRT17 may be a new target for endometrial cancer treatment because it helps cancer cells move and form new blood vessels.

Activating liver X receptors can reduce fibrosis by stopping certain immune cells from releasing harmful proteins.

A new therapy for a skin blistering condition has not been developed yet.

Bedaquiline, Telmisartan, Diosmin, Azelastine, and Adapalene may be effective treatments for onchocerciasis.

Higher TGF-β signaling may increase skin cancer risk in organ transplant recipients.

RAGE is a potential target for melanoma treatment, but its effectiveness is uncertain due to variable expression levels.

Sorafenib causes skin reactions by increasing the number and activity of skin mast cells.

Overexpression of E2F1 can lead to skin tumors and disrupt hair growth.

Blocking the CXCR3 receptor reduces T cell accumulation in the skin and prevents hair loss in mice.

MK-5108 is safe and shows potential against tumors, especially alone.

Myricetin shows promise as an anticancer agent by reducing inflammation and enhancing drug effectiveness.

New markers can detect tumors, aid drug delivery, and treat cancer effectively and safely.

The combination of TACE and Donafenib is effective and tolerable for treating unresectable liver cancer.

Blocking mTORC1 activity with rapamycin could help increase hair pigmentation and growth, potentially reversing gray hair.

JAK inhibitors help hair growth by boosting beta-catenin activity in hair root cells.

Danoprevir, remdesivir, and saridegib may effectively inhibit SARS-CoV-2.

New therapies for Birt–Hogg–Dubé syndrome are being developed based on understanding the FLCN gene's role.

The new assay can help develop products for hair re-growth.

Antisense oligonucleotides can reduce androgen receptor levels in skin cells, suggesting potential for treating skin disorders.

Repurposing existing drugs can improve cancer treatment but faces challenges.

Blocking RANK signaling might help treat metastatic melanoma, but more research is needed.

The topical inhibitor CUR61414 was not effective in treating basal cell carcinoma in human trials.

Ruxolitinib helped a woman with a genetic mutation regrow her hair and improved her health.

Antizyme slows skin tumor growth by reducing cell growth in mice.

Igf1r helps regulate hair growth cycles.

Sonidegib is effective and safe for treating advanced basal cell carcinoma, but biopsies are needed to confirm tumor clearance.

EGF receptors are crucial for skin cell growth and decrease with age.

Targeting vitamin D and androgen receptors may effectively treat triple-negative breast cancer, especially with chemotherapy.